S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS: RESULTS FROM THE EURO-SKI STUDY

• Fabio Efficace,
• Francois-Xavier Mahon,
• Johan Richter,
• Alfonso Piciocchi,
• Marta Cipriani,
• Franck Emmanuel Nicolini,
• Henrik Hjorth-Hansen,
• Antonio Almeida,
• Jeroen J. W. M. Janssen,
• Jiri Mayer,
• Perttu Koskenvesa,
• Panayiotis Panayiotidis,
• Ulla Olsson-Strömberg,
• Joaquín Martinez-Lopez,
• Philippe Rousselot,
• Hanne Vestergaard,
• Hans Ehrencrona,
• Veli Kairisto,
• Katerina Machova Polakova,
• Satu Mustjoki,
• Marc Berger,
• Andreas Hochhaus,
• Markus Pfirrmann,
• Susanne Saussele

Affiliations

Fabio Efficace

1 Italian Group for Adult Haematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy

Francois-Xavier Mahon

2 Institut Bergonié, Service d’Hématologie Clinique, Bordeaux, France

Johan Richter

3 Skåne University Hospital, Department of Hematology, Oncology and Radiation Physics, Lund, Sweden

Alfonso Piciocchi

1 Italian Group for Adult Haematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy

Marta Cipriani

1 Italian Group for Adult Haematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy

Franck Emmanuel Nicolini

5 Centre Léon Bérard, Service d’Hématologie Clinique & INSERM U1052 CRCL, Lyon, France

Henrik Hjorth-Hansen

6 St Olavs Hospital, Department of Hematology, Trondheim, Norway

Antonio Almeida

7 Hospital da Luz, Faculdade de Medicina, Universidade Católica Portuguesa, Department of Hematology, Lisbon, Portugal

Jeroen J. W. M. Janssen

8 Radboud UMC, Department of Haematology, Nijmegen, The Netherlands

Jiri Mayer

9 Masaryk University Hospital, Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic

Perttu Koskenvesa

10 Hematology Research Unit Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland

Panayiotis Panayiotidis

11 National and Kapodistrian University of Athens, First Propedeutic Department of Internal Medicine, Athens, Greece

Ulla Olsson-Strömberg

12 Uppsala University Hospital, Department of Medical Sciences, Uppsala University and Hematology Section, Uppsala, Sweden

Joaquín Martinez-Lopez

13 Universidad Complutense de Madrid, Hematology, Hospital Universitario 12 de Octubre, CNIO, Madrid, Spain

Philippe Rousselot

14 CH Versailles, Department of Haemato-Oncology, Versailles, France

Hanne Vestergaard

15 Odense University Hospital, Quality of Life Research Center, Department of Haematology, Odense, Denmark

Hans Ehrencrona

16 Department of Clinical Genetics, Pathology and Molecular Diagnostics, Office for Medical Services, Region Skåne, Lund, Sweden; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden

Veli Kairisto

17 Turku University Central Hospital, Department of Clinical Chemistry and Department of Genetics, Turku, Finland

Katerina Machova Polakova

18 Institute of Haematology and Blood Transfusion, Prague, Czech Republic

Satu Mustjoki

19 University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Hematology Research Unit Helsinki, Helsinki, Finland

Marc Berger

20 CHU Estaing and Université Clermont Auvergne, Hématologie Biologique and Equipe d’Accueil 7453 Hemopaties Chroniques: Heterogeneite Intra-clonale, Microenvironnement et Resistance Therapeutique, Clermont-Ferrand, France

Andreas Hochhaus

21 Universitätsklinikum Jena, Klinik für Innere Medizin II, Jena, Germany

Markus Pfirrmann

22 Ludwig-Maximilians-Universität, Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Munich, Germany

Susanne Saussele

23 Heidelberg University, Department of Haematology and Oncology, University Hospital Mannheim, Mannheim, Germany